London
· Delayed Price · Currency is GBP · Price in GBXAbingdon Health Statistics
Total Valuation
Abingdon Health has a market cap or net worth of GBP 37.15 million. The enterprise value is 36.16 million.
| Market Cap | 37.15M |
| Enterprise Value | 36.16M |
Important Dates
The next estimated earnings date is Thursday, October 17, 2024.
| Earnings Date | Oct 17, 2024 |
| Ex-Dividend Date | n/a |
Share Statistics
Abingdon Health has 381.06 million shares outstanding. The number of shares has increased by 0.04% in one year.
| Shares Outstanding | 381.06M |
| Shares Change (YoY) | +0.04% |
| Shares Change (QoQ) | +0.00% |
| Owned by Insiders (%) | 7.13% |
| Owned by Institutions (%) | 19.74% |
| Float | 160.58M |
Valuation Ratios
| PE Ratio | n/a |
| Forward PE | n/a |
| PS Ratio | 5.55 |
| PB Ratio | 16.34 |
| P/FCF Ratio | n/a |
| PEG Ratio | n/a |
Enterprise Valuation
| EV / Earnings | -16.18 |
| EV / Sales | 6.77 |
| EV / EBITDA | n/a |
| EV / EBIT | n/a |
| EV / FCF | -15.70 |
Financial Position
The company has a current ratio of 1.79, with a Debt / Equity ratio of 55.57.
| Current Ratio | 1.79 |
| Quick Ratio | 1.59 |
| Debt / Equity | 55.57 |
| Debt / EBITDA | n/a |
| Debt / FCF | -0.44 |
| Interest Coverage | -33.68 |
Financial Efficiency
Return on equity (ROE) is -76.65% and return on invested capital (ROIC) is -39.80%.
| Return on Equity (ROE) | -76.65% |
| Return on Assets (ROA) | -26.52% |
| Return on Capital (ROIC) | -39.80% |
| Revenue Per Employee | 63,619 |
| Profits Per Employee | -26,607 |
| Employee Count | 82 |
| Asset Turnover | 0.90 |
| Inventory Turnover | 7.67 |
Taxes
| Income Tax | n/a |
| Effective Tax Rate | n/a |
Stock Price Statistics
The stock price has decreased by -11.38% in the last 52 weeks.
| Beta (5Y) | n/a |
| 52-Week Price Change | -11.38% |
| 50-Day Moving Average | 10.26 |
| 200-Day Moving Average | 9.77 |
| Relative Strength Index (RSI) | 44.09 |
| Average Volume (20 Days) | 102,855 |
Short Selling Information
| Short Interest | n/a |
| Short Previous Month | n/a |
| Short % of Shares Out | n/a |
| Short % of Float | n/a |
| Short Ratio (days to cover) | n/a |
Income Statement
In the last 12 months, Abingdon Health had revenue of GBP 5.34 million and -2.24 million in losses. Loss per share was -0.01.
| Revenue | 5.34M |
| Gross Profit | 3.07M |
| Operating Income | -2.53M |
| Pretax Income | -2.37M |
| Net Income | -2.24M |
| EBITDA | -1.94M |
| EBIT | -2.53M |
| Loss Per Share | -0.01 |
Balance Sheet
The company has 2.00 million in cash and 1.01 million in debt, giving a net cash position of 990,000 or 0.00 per share.
| Cash & Cash Equivalents | 2.00M |
| Total Debt | 1.01M |
| Net Cash | 990,000 |
| Net Cash Per Share | 0.00 |
| Equity (Book Value) | 1.81M |
| Book Value Per Share | 0.01 |
| Working Capital | 1.66M |
Cash Flow
In the last 12 months, operating cash flow was -2.25 million and capital expenditures -53,000, giving a free cash flow of -2.30 million.
| Operating Cash Flow | -2.25M |
| Capital Expenditures | -53,000 |
| Free Cash Flow | -2.30M |
| FCF Per Share | -0.01 |
Margins
Gross margin is 57.35%, with operating and profit margins of -47.27% and -41.82%.
| Gross Margin | 57.35% |
| Operating Margin | -47.27% |
| Pretax Margin | -44.35% |
| Profit Margin | -41.82% |
| EBITDA Margin | -36.36% |
| EBIT Margin | -47.27% |
| FCF Margin | -43.11% |
Dividends & Yields
Abingdon Health does not appear to pay any dividends at this time.
| Dividend Per Share | n/a |
| Dividend Yield | n/a |
| Dividend Growth (YoY) | n/a |
| Years of Dividend Growth | n/a |
| Payout Ratio | n/a |
| Buyback Yield | -0.04% |
| Shareholder Yield | -0.04% |
| Earnings Yield | -7.59% |
| FCF Yield | -6.20% |
Stock Splits
This stock does not have any record of stock splits.
| Last Split Date | n/a |
| Split Type | n/a |
| Split Ratio | n/a |